Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus

CONCLUSIONS: Empagliflozin may be a promising neuroprotective and therapeutic agent for diabetic peripheral neuropathy. Trial registration Identifier: NCT05977465.PMID:38653618 | DOI:10.1016/j.medcli.2024.01.027

Source: Medicina Clinica - April 23, 2024 Category: General Medicine Authors: Sahar Mohamed El-Haggar Yasser Mostafa Hafez Amira Mohamed El Sharkawy Maha Khalifa Source Type: research